National decision-making for the introduction of new vaccines: A systematic review, 2010–2020
Open Access
- 1 April 2021
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 39 (14), 1897-1909
- https://doi.org/10.1016/j.vaccine.2021.02.059
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
This publication has 127 references indexed in Scilit:
- Embedding health policy and systems research into decision-making processes in low- and middle-income countriesHealth Research Policy and Systems, 2013
- Pandemic H1N1 in Canada and the use of evidence in developing public health policies – A policy analysisSocial Science & Medicine (1982), 2013
- Q&A - Economic analyses for vaccine introduction decisions in low- and middle- income countriesBMC Medicine, 2013
- Implementation of Human Papillomavirus Immunization in the Developing WorldVaccine, 2012
- New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGsVaccine, 2012
- Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventionsHealth Policy and Planning, 2012
- Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type b vaccine experiencePhilosophical Transactions B, 2011
- The future of immunisation policy, implementation, and financingThe Lancet, 2011
- Evidence and policymaking: The introduction of MMR vaccine in the NetherlandsSocial Science & Medicine (1982), 2010
- The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative: A country-driven, multi-partner program to support evidence-based decision makingVaccine, 2010